Max joined the group as a PhD student in August 2024 after completing a research project and master thesis with the group. He studied Chemical Biotechnology at the University of Munich (B.Sc.) and Bioinformatics at the University of Tübingen (M.Sc.). In his PhD project he is mainly working on the understanding of hepatocellular carcinoma for the THRIVE initative.
